Search Results
Oct 15, 2025, 15:20 ET Tire Market to Reach USD 462.9 billion by 2032, Growing At An 4.34% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 15, 2025, 11:30 ET SJinn Shatters AI Video Limits, Integrating Sora2 and Veo3 for Minute-Long, Character-Consistent Storytelling
VEO Story Short: [https://sjinn.ai/templates/9b371ec6-09a2-43d5-97c2-0aea79a12371] The era of fragmented
More news about: SJinn AI
Oct 14, 2025, 15:31 ET Health and Wellness Food Market to Reach USD 2,177.10 billion by 2032, Growing At An 9.80% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 14, 2025, 14:31 ET GCC Medical Tourism Market to Reach USD 889.97 million by 2032, Growing At An 10.26% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 14, 2025, 12:00 ET Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress
mg/kg or above and reaching tumor assessment, 19 partial responses (PRs) or complete responses (CRs) were observed. 7 patients with esophageal cancer (EC) were enrolled at 4.0 mg/kg or above and achieved an objective response rate (ORR) of 42.9% and a disease control rate (DCR) of 100%. Among lung cancer
More news about: Mabwell
Oct 14, 2025, 09:00 ET zeb Achieves ServiceNow Premier Partner Status
ServiceNow. From the world's first Salesforce-to-ServiceNow Migration Framework and the AI Assessment Framework to Lightning Implementation and EC Portal Packages, zeb brings together innovation and execution speed to enable seamless onboarding, faster value realization, and measurable ROI from
More news about: zeb
Oct 14, 2025, 07:10 ET Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior
effectiveness of fenfluramine in children and adults with Dravet syndrome. Epilepsia. 2025;66(6):1919-32. Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper
More news about: UCB
Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics
research and development, beginning to help patients close to where it all started." Leqembi received the European Commission (EC) approval in April 2025 as the first therapy that targets an underlying cause of Alzheimer's disease (AD). It is indicated for the treatment of adult
More news about: BioArctic
Oct 13, 2025, 15:42 ET Gemstones Market to Reach USD 101.01 Billion by 2032, Growing At An 6.3% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 13, 2025, 15:21 ET Sustainable Bags Market to Reach USD 6.05 Billion by 2032, Growing At An 12.8% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 13, 2025, 15:03 ET Algae Products Market to Reach USD 9.7Billion by 2032, Growing At An 7% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 13, 2025, 09:00 ET Simpson Manufacturing Co., Inc. to Announce Third Quarter 2025 Financial Results on Monday, October 27th
https://viavid.webcasts.com/starthere.jsp?ei=1735146&tp_key=4ec4ebc4d2
More news about: Simpson Manufacturing Co., Inc.
Oct 13, 2025, 00:01 ET Strategy Consulting Market to Reach USD 96.2 Billion by 2032, Growing At An 11.9% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 09, 2025, 18:56 ET Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
EYDENZELT is Celltrion's first FDA-approved biologic product in ophthalmology. EYDENZELT was also approved by the European Commission (EC) in February 2025. ### About EYDENZELT®
More news about: Celltrion
Oct 09, 2025, 14:38 ET Foundry Market to Reach USD 171.70 Billion by 2032, Growing At An 3.99% CAGR - Credence Research
imperative objectives. Contact UsCredence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 09, 2025, 09:00 ET European Commission Awards Cybersecurity Contract to Unisys-Led Consortium
Unisys (NYSE: UIS) has been selected by the European Commission (EC) to play a key role in its Cybersecurity Professional Services Framework Contract (FREIA), delivering critical cybersecurity operations to public institutions
More news about: Unisys Corporation
Oct 08, 2025, 17:31 ET Sustainable Footwear Market: Poised to Reach USD 15.9 Billion by 2032, Credence Research Finds
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 08, 2025, 17:31 ET Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New Treatment Launches | DelveInsight
with cardiomyopathy (ATTR-CM) in 2025. In June 2025, Alnylam Pharmaceuticals announced that the European Commission (EC) had approved an additional indication for AMVUTTRA (vutrisiran), an orphan RNAi therapeutic, for the treatment of wild-type or hereditary transthyretin
More news about: DelveInsight Business Research, LLP
Oct 08, 2025, 15:37 ET Specialty Coffee Market to Reach USD 69.8 Billion Globally by 2032, Growing at a CAGR of 4.75% -- Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 08, 2025, 07:00 ET Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
About the Phase 3 XPORT-EC-042 Trial EC-042 (XPORT-EC-042;
More news about: Karyopharm Therapeutics Inc.
Oct 07, 2025, 15:19 ET Interior Design Market to Reach USD 222.2 Billion Globally by 2032, Growing At An 5.45% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 07, 2025, 15:09 ET T-Shirts Market to Reach USD 221.5 Billion Globally by 2032, Growing At An 4.1% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 07, 2025, 08:05 ET TREMFYA® (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis
established with IV induction." TREMFYA® has received U.S. Food and Drug Administration (FDA) and European Commission (EC) approval for both SC and IV induction options for the treatment of adults with moderately to severely active Crohn's disease and U.S. FDA approval for
More news about: Johnson & Johnson
Oct 06, 2025, 15:25 ET Luxury Tourism Market to Reach USD 2,963.2 Billion by 2032, Growing At An 3.62% CAGR - Credence Research
Contact Us Credence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Oct 06, 2025, 11:28 ET LifeZoom Elevates Your Wellness Routine This Autumn with Red Light Therapy Wand
[2] DE Oliveira MF, Johnson DS, Demchak T, Tomazoni SS, Leal-Junior EC. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions. Eur J Phys Rehabil Med. 2022
More news about: Lifezoom